Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases: A Nonrandomized Phase 2 Trial.
Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ advanced/metastatic breast cancer (mBC) with or without brain metastases (BM): DESTINYBreast-12 primary results.
Impactful Shortlisted Abstracts/Publications in HER2+ve Breast Cancer
Chairpersons :
Dr. Vinod Raina, Dr. K. K. Mukherjee
Speaker :
Dr. Aparna Sreevatsa